Elderly Patients With Renal Insufficiency: Reasons for Using the Geriatrician, Modalities and Results of the Geriatric Evaluation, Becoming at One Year (NephroG)
The incidence and prevalence of kidney failure increases with age. Elderly people with chronic kidney disease may have factors of fragility (loss of independence, comorbidities, geriatric syndromes) that can complicate the choice and implementation of the nephrological therapeutic project. Joint and early assessment of these patients by a nephrologist and a geriatrician could help to optimize the definition of care objectives and patient pathway.
There is little data on how nephrologists and geriatricians cooperate and on the description of frailties in elderly patients with renal impairment.
In this context, the objective of this study is to describe in a French university hospital the reasons for the use of geriatricians by nephrologists, the modalities of geriatric evaluation and the socio-demographic and medical characteristics (including geriatric syndromes) of very elderly patients with renal insufficiency, and then to become so at one year.
Year of implementation of this research: 2019 based on data from 2017 and 2019. Approximate number of people likely to be included in the research: 100 patients
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
There is little data on how nephrologists and geriatricians cooperate and on the description of frailties in elderly patients with renal impairment.
In this context, the objective of this study is to describe in a French university hospital the reasons for the use of geriatricians by nephrologists, the modalities of geriatric evaluation and the socio-demographic and medical characteristics (including geriatric syndromes) of very elderly patients with renal insufficiency, and then to become so at one year.
Secondary objectives :
- describe the modalities of the geriatric evaluation
- describe the socio-demographic, medical characteristics (including fragilities and/or geriatric syndromes) of elderly patients with renal insufficiency
- describe how to become one year old.
Origin and nature of the data collected:
- Socio-demographic, medical and geriatric data (see attached document) based on geriatric assessment medical records (reports of external geriatric consultation and/or intervention by the mobile geriatric team).
The approximate duration of the study will be 9 months. This time includes the time required for statistical analysis and writing an article.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
-
Nîmes, Francia, 30029
- CHU de Nîmes
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- 75-year-old patient and older
- Renal insufficiency
- Use in 2017 and 2018 of a geriatric evaluation at the Nîmes University Hospital at the request of nephrologists (mobile geriatric team or external geriatric consultation).
Exclusion Criteria:
- Patient under guardianship, curatorship or judicial protection
- Patient under 75-year-old
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
reason for the nephrologist's recourse for a geriatric assessment with a geriatric team
Lasso di tempo: up to one year
|
geriatric syndromes recorded from medical records
|
up to one year
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
geriatric advice for therapeutic project including dialysis option
Lasso di tempo: up to one year
|
rate of geriatric advice for therapeutic project including dialysis option listed from medical records
|
up to one year
|
|
falls recorded from geriatric assessment medical records
Lasso di tempo: up to one year
|
number of falls recorded from geriatric assessment medical records
|
up to one year
|
|
death,assessment from medical records
Lasso di tempo: at one year
|
number of death recorded from medical records
|
at one year
|
|
dialyses and death recorded from medical records
Lasso di tempo: at one year
|
rate of dialyses and death recorded from medical records
|
at one year
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- Local/2019/VA-1
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su geriatric nephrology
-
Alberto PilottoReclutamentoPersone anziane | Malattie croniche non trasmissibiliItalia
-
CelgeneCompletatoSindromi mielodisplastiche | Mieloma multiplo | Leucemia mieloide acuta | Leucemia, linfocitica, cronicaSpagna
-
University of California, San FranciscoNational Institute on Aging (NIA); Mount Zion Health FundCompletato
-
Universitaire Ziekenhuizen KU LeuvenCHU UCL NamurCompletato
-
Dana-Farber Cancer InstituteEMD Serono; National Comprehensive Cancer NetworkReclutamentoCancro alla vescica | Carcinoma uroteliale | Cancro alla vescica metastatico | Carcinoma vescicale non resecabileStati Uniti